Trinity, St. James’s and Legend Biotech collaborating on solid tumors
Trinity College and St. James’s Hospital Dublin (SJH) in Ireland have entered into a strategic…
Trinity College and St. James’s Hospital Dublin (SJH) in Ireland have entered into a strategic…
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
The Portuguese company CellmAbs is developing cancer immunotherapies that prevent tumor cells from evading the…
iOnctura, a spinout from Merck KGaA, has raised €15M to take its cancer and fibrosis…
One of the greatest challenges faced by researchers in preclinical oncology studies is the translatability…
The UK biotech Cell Medica has received a €7.6M ($8.7M) grant from the Cancer Prevention…
CAR-T cell therapy has been able to effectively treat cancer in some patients for whom…
A Phase I study will investigate the safety and tolerability of Immatics approach to treating…
Immatics will start a first clinical trial to test IMA101, a personalized cell therapy with…
Immunicum has reported new data on long-term follow-up of patients treated with ilixadencel, a unique…
Apogenix' partner AbbVie has started the first clinical trial for an immuno-oncology candidate with the…
David Sourdive, co-founder of Cellectis, discusses his pioneering work developing off-the-shelf CAR-T for cancer and…